| Methods |
RCT
Open
1996‐1997 |
| Participants |
Number: 38 patients (45 episodes)
Age: mean 44, SD 16 |
| Interventions |
cefepime 2grx 3
versus
ceftazidime 2grx3 |
| Outcomes |
Overall and infection‐related mortality ‐ at 14 days after end of treatment
Clinical and microbiological failure
Drug modifications
Adverse events |
| Notes |
Taiwan |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Adequate sequence generation? |
Unclear risk |
No description |
| Allocation concealment? |
Unclear risk |
No description |
| Blinding?
All outcomes |
High risk |
Blinding not used |
| Incomplete outcome data addressed?
All‐cause mortality |
High risk |
9% dropouts |
| Incomplete outcome data addressed?
Treatment failure |
High risk |
Number of dropouts (9%) known per study group |
| Free of other bias? |
High risk |
Unit of randomization = episodes; patients to episodes ratio 0.84 |
